KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis
USA - NYSE:PHG - US5004723038
28.2 USD
-0.42 (-1.47%)
28.2 USD
0 (0%)
PHG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of PHG while its profitability can be described as average. PHG has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
PHG had positive earnings in the past year.
PHG had a positive operating cash flow in the past year.
In multiple years PHG reported negative net income over the last 5 years.
Of the past 5 years PHG 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of PHG (0.61%) is better than 72.77% of its industry peers.
With a decent Return On Equity value of 1.56%, PHG is doing good in the industry, outperforming 73.82% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.49%, PHG is doing good in the industry, outperforming 74.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.49% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.91%, PHG is in the better half of the industry, outperforming 73.30% of the companies in the same industry.
Looking at the Operating Margin, with a value of 6.11%, PHG is in the better half of the industry, outperforming 71.73% of the companies in the same industry.
PHG's Operating Margin has declined in the last couple of years.
PHG's Gross Margin of 43.85% is on the low side compared to the rest of the industry. PHG is outperformed by 63.35% of its industry peers.
In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHG is destroying value.
PHG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHG has more shares outstanding
Compared to 1 year ago, PHG has a worse debt to assets ratio.
2.2 Solvency
PHG has an Altman-Z score of 1.93. This is not the best score and indicates that PHG is in the grey zone with still only limited risk for bankruptcy at the moment.
PHG's Altman-Z score of 1.93 is fine compared to the rest of the industry. PHG outperforms 60.73% of its industry peers.
The Debt to FCF ratio of PHG is 19.41, which is on the high side as it means it would take PHG, 19.41 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 19.41, PHG is doing good in the industry, outperforming 71.20% of the companies in the same industry.
PHG has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHG is somewhat dependend on debt financing.
PHG's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHG is outperformed by 70.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.7
WACC6.41%
2.3 Liquidity
PHG has a Current Ratio of 1.26. This is a normal value and indicates that PHG is financially healthy and should not expect problems in meeting its short term obligations.
PHG has a worse Current ratio (1.26) than 79.58% of its industry peers.
A Quick Ratio of 0.81 indicates that PHG may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.81, PHG is doing worse than 85.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
PHG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.17%, which is quite good.
PHG shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -1.53% in the last year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
3.2 Future
PHG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.35% yearly.
Based on estimates for the next years, PHG will show a small growth in Revenue. The Revenue will grow by 3.00% on average per year.
EPS Next Y1.18%
EPS Next 2Y6.04%
EPS Next 3Y8.31%
EPS Next 5Y12.35%
Revenue Next Year-1.66%
Revenue Next 2Y0.97%
Revenue Next 3Y2.19%
Revenue Next 5Y3%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.69, PHG is valued correctly.
Based on the Price/Earnings ratio, PHG is valued cheaper than 82.72% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. PHG is valued slightly cheaper when compared to this.
PHG is valuated correctly with a Price/Forward Earnings ratio of 15.45.
PHG's Price/Forward Earnings ratio is rather cheap when compared to the industry. PHG is cheaper than 82.72% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, PHG is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.69 | ||
| Fwd PE | 15.45 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHG is valued cheaper than 86.39% of the companies in the same industry.
PHG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PHG is cheaper than 75.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.4 | ||
| EV/EBITDA | 12.48 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)14.1
PEG (5Y)N/A
EPS Next 2Y6.04%
EPS Next 3Y8.31%
5. Dividend
5.1 Amount
PHG has a Yearly Dividend Yield of 3.05%.
PHG's Dividend Yield is rather good when compared to the industry average which is at 1.69. PHG pays more dividend than 98.95% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, PHG pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
5.2 History
The dividend of PHG decreases each year by -70.49%.
PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
0.62% of the earnings are spent on dividend by PHG. This is a low number and sustainable payout ratio.
DP0.62%
EPS Next 2Y6.04%
EPS Next 3Y8.31%
28.2
-0.42 (-1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners42.8%
Inst Owner Change-17.46%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap27.15B
Analysts75.38
Price Target32.63 (15.71%)
Short Float %0.48%
Short Ratio3.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)3.84%
PT rev (3m)5.51%
EPS NQ rev (1m)1.27%
EPS NQ rev (3m)-12.9%
EPS NY rev (1m)-7.96%
EPS NY rev (3m)-7.96%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-5.99%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-2.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.69 | ||
| Fwd PE | 15.45 | ||
| P/S | 1.3 | ||
| P/FCF | 53.4 | ||
| P/OCF | 21.09 | ||
| P/B | 2.23 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.48 |
EPS(TTM)1.69
EY5.99%
EPS(NY)1.83
Fwd EY6.47%
FCF(TTM)0.53
FCFY1.87%
OCF(TTM)1.34
OCFY4.74%
SpS21.73
BVpS12.63
TBVpS-2.06
PEG (NY)14.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.49% | ||
| ROICexc | 4.97% | ||
| ROICexgc | 16.33% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.93 |
F-Score8
WACC6.41%
ROIC/WACC0.7
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
EPS Next Y1.18%
EPS Next 2Y6.04%
EPS Next 3Y8.31%
EPS Next 5Y12.35%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
Revenue Next Year-1.66%
Revenue Next 2Y0.97%
Revenue Next 3Y2.19%
Revenue Next 5Y3%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.08%
EBIT Next 3Y20.59%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%